CBDV binds to the endocannabinoid system (ECS) and transient receptor potential channels like TRPV1 and TRPA1. It also has anti-nausea properties.
CBDV has shown great promise in treating neuropathic pain, autism, and seizures.
Research has shown CBDV effectively alleviates neuropathic pain from conditions such as multiple sclerosis. It has also successfully treated chronic pain and reduced the need for opioids, which have unwanted side effects.
Studies have also found that CBDV is an antiemetic that relieves nausea. It works as an inverse agonist at CB1 receptors, blocking the nerve pathways that cause nausea. It has been more effective than THCV at this.
Additionally, CBDV can help people with seizures caused by epilepsy, as it has been found to inhibit the endocannabinoid system’s activation. It also has desensitizing properties for TRP ion channels, which reduce the activity of the hippocampus and thus decrease seizures.
Inflammation is a normal body response to fight threats such as infections or irritants. However, it can become dangerous when inflammation persists and is not treated effectively. Usually, doctors treat inflammation by removing the source of the issue or taking anti-inflammatory medications such as NSAIDs.
However, studies now show that CBDV can also reduce inflammation and improve the overall health of patients with chronic diseases. So what is CBDV? CBDV is a non-psychoactive cannabinoid discovered over five decades ago but has only recently gained the attention of the public and medical community.
In one study published in 2019 in the Journal of Translational Psychiatry, researchers studied how CBDV affects glutamate and GABA metabolites in the brain. The results showed that CBDV does reduce cortical and subcortical GM and WM glutamate and GABA, respectively, in ASD individuals. This is an important finding because subtle E-I alterations in these circuits have been linked to ASD symptoms. The results suggest that CBDV may be a useful treatment for ASD.
Migraine sufferers are often able to find Relief with CBD. It interacts with the endocannabinoid system (ECS) to reduce the symptoms of migraines, such as nausea and pain. It can also limit the breakdown of anandamide, a neurotransmitter that regulates endocannabinoid levels.
CBDV is similar to CBD but seems to have a stronger effect on certain brain receptors, making it better for mood disorders and overcoming nausea. It also appears to have more powerful anticonvulsant properties, making it helpful for neurological issues like migraine pain and seizures.
Some people report that CBDV is an effective treatment for migraines and other headaches, including tension and cluster headaches. Many people recommend starting with low doses and gradually increasing the dosage until they notice pain-relieving effects to avoid a high. If you choose to try CBDV, make sure you buy products that have been third-party tested for purity and potency. Always consult a medical professional before attempting any new treatment.
Pain management is a broad term encompassing different treatment methods for various types of pain. It is often a complex and involved process that requires a team of health experts. This includes physicians from different specialties, such as neurology and anesthesiology, as well as a psychiatrist who can help patients deal with the emotions that come with pain.
Pain is a sensation that comes from messages sent between the brain and specialized nerves. It can be sharp, aching, burning, or dull and vary from person to person. Sometimes it even feels like it’s coming from one part of the body when it isn’t, such as a heart attack that causes pain in the chest and left arm.
CBDV has shown a tendency to decrease the activity of certain nerve cells involved in inflammation, seizures, and pain. It has also been found to desensitize TRPV1 receptors, which are involved in pain and capsaicin sensations.